 | • レポートコード：MRC2102QY11636 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のプロカルシトニン抗体市場について種類別（ポリクローナルプロカルシトニン抗体、モノクローナルプロカルシトニン抗体）、用途別（病院、医学研究機関、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・プロカルシトニン抗体市場の概要 ・世界の主要地域別プロカルシトニン抗体市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のプロカルシトニン抗体市場規模2015-2026：種類別（ポリクローナルプロカルシトニン抗体、モノクローナルプロカルシトニン抗体） ・世界のプロカルシトニン抗体市場規模2015-2026：用途別（病院、医学研究機関、その他） ・プロカルシトニン抗体の米国市場規模2015-2020 ・プロカルシトニン抗体のヨーロッパ市場規模2015-2020 ・プロカルシトニン抗体の中国市場規模2015-2020 ・プロカルシトニン抗体の日本市場規模2015-2020 ・プロカルシトニン抗体の東南アジア市場規模2015-2020 ・プロカルシトニン抗体のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・プロカルシトニン抗体の製造コスト分析 ・販売チャネル、流通業者、顧客 ・プロカルシトニン抗体の市場動向・機会・課題 ・調査の結論 |
Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue, calcitonin and katacalcin. It can be expressed in E. coli.Procalcitonin Antibody refers to the specific protein which can qualitatively and quantitatively detect the PCT level. PCT level is a parameter for the diagnosis and monitoring of bacterial inflammatory diseases
Sepsis is a life-threatening organ dysfunction caused by an excessive host immune response to a serious infection. According to the Centers for Disease Control and Prevention (CDC), 1.6 million Americans suffered from sepsis in 2011, of which about 260,000 did not survive. PCT can play a critical role in addressing this clinical challenge and has become a key component of successful sepsis protocols across the U.S. and Europe. PCT levels increase precipitously in patients with severe bacterial infection. PCT is therefore an extremely important biomarker enabling specific differentiation between a severe bacterial infection and other causes of inflammatory reactions.
The technical barriers of procalcitonin antibody are high and the procalcitonin antibody production concentrated large companies including Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, etc. The sales revenue of top five manufacturers accounted for 37.9% in 2016. Thermo Fisher is the largest manufacturer in the world, which sales reached 2.48g in China.
The manufacture region is concentrated in South China, East China and Southwest China, of which East China is the largest region with the share 24.28% in 2016. The sales shares of Southwest China and South China were 15.59% and 14.79%.
There are companies adding new capacities and aims at the cost and quality leadership which shall improve profitability. As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. The competition in procalcitonin antibody market will become more intense.
Market Analysis and Insights: Global Procalcitonin Antibody Market
The global Procalcitonin Antibody market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Procalcitonin Antibody Scope and Market Size
The global Procalcitonin Antibody market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Procalcitonin Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Procalcitonin Antibody market is segmented into
Polyclonal Procalcitonin Antibody
Monoclonal Procalcitonin Antibody
Segment by Application, the Procalcitonin Antibody market is segmented into
Hospital
Medical research institutions
Others
The Procalcitonin Antibody market is analysed and market size information is provided by regions (countries). Segment by Application, the Procalcitonin Antibody market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Procalcitonin Antibody Market Share Analysis
Procalcitonin Antibody market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Procalcitonin Antibody business, the date to enter into the Procalcitonin Antibody market, Procalcitonin Antibody product introduction, recent developments, etc.
The major vendors covered:
Thermo Fisher
Roche Diagnostics
bioMerieux
HyTest
Wondfo
Ningbo Medicalsystem Biotechnology
Snibe
Vazyme Biotech
Getein Biotech
Hotgen Biotech
Lumigenex
Shanghai Medicine’nest Pharmaceutical
Kitgen
Beijing KeyGen
Fantibody
1 Procalcitonin Antibody Market Overview
1.1 Procalcitonin Antibody Product Scope
1.2 Procalcitonin Antibody Segment by Type
1.2.1 Global Procalcitonin Antibody Sales by Type (2020-2026)
1.2.2 Polyclonal Procalcitonin Antibody
1.2.3 Monoclonal Procalcitonin Antibody
1.3 Procalcitonin Antibody Segment by Application
1.3.1 Global Procalcitonin Antibody Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Medical research institutions
1.3.4 Others
1.4 Procalcitonin Antibody Market Estimates and Forecasts (2015-2026)
1.4.1 Global Procalcitonin Antibody Sales Growth Rate (2015-2026)
1.4.2 Global Procalcitonin Antibody Revenue and Growth Rate (2015-2026)
1.4.3 Global Procalcitonin Antibody Price Trends (2015-2026)
2 Procalcitonin Antibody Estimate and Forecast by Region
2.1 Global Procalcitonin Antibody Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Procalcitonin Antibody Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Procalcitonin Antibody Sales Market Share by Region (2015-2020)
2.2.2 Global Procalcitonin Antibody Revenue Market Share by Region (2015-2020)
2.3 Global Procalcitonin Antibody Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Procalcitonin Antibody Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Procalcitonin Antibody Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Procalcitonin Antibody Estimates and Projections (2015-2026)
2.4.2 Europe Procalcitonin Antibody Estimates and Projections (2015-2026)
2.4.3 China Procalcitonin Antibody Estimates and Projections (2015-2026)
2.4.4 Japan Procalcitonin Antibody Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Procalcitonin Antibody Estimates and Projections (2015-2026)
2.4.6 India Procalcitonin Antibody Estimates and Projections (2015-2026)
3 Global Procalcitonin Antibody Competition Landscape by Players
3.1 Global Top Procalcitonin Antibody Players by Sales (2015-2020)
3.2 Global Top Procalcitonin Antibody Players by Revenue (2015-2020)
3.3 Global Procalcitonin Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Procalcitonin Antibody as of 2019)
3.4 Global Procalcitonin Antibody Average Price by Company (2015-2020)
3.5 Manufacturers Procalcitonin Antibody Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Procalcitonin Antibody Players (Opinion Leaders)
4 Global Procalcitonin Antibody Market Size by Type
4.1 Global Procalcitonin Antibody Historic Market Review by Type (2015-2020)
4.1.1 Global Procalcitonin Antibody Sales Market Share by Type (2015-2020)
4.1.2 Global Procalcitonin Antibody Revenue Market Share by Type (2015-2020)
4.1.3 Global Procalcitonin Antibody Price by Type (2015-2020)
4.2 Global Procalcitonin Antibody Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Procalcitonin Antibody Sales Forecast by Type (2021-2026)
4.2.2 Global Procalcitonin Antibody Revenue Forecast by Type (2021-2026)
4.2.3 Global Procalcitonin Antibody Price Forecast by Type (2021-2026)
5 Global Procalcitonin Antibody Market Size by Application
5.1 Global Procalcitonin Antibody Historic Market Review by Application (2015-2020)
5.1.1 Global Procalcitonin Antibody Sales Market Share by Application (2015-2020)
5.1.2 Global Procalcitonin Antibody Revenue Market Share by Application (2015-2020)
5.1.3 Global Procalcitonin Antibody Price by Application (2015-2020)
5.2 Global Procalcitonin Antibody Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Procalcitonin Antibody Sales Forecast by Application (2021-2026)
5.2.2 Global Procalcitonin Antibody Revenue Forecast by Application (2021-2026)
5.2.3 Global Procalcitonin Antibody Price Forecast by Application (2021-2026)
6 United States Procalcitonin Antibody Market Facts & Figures
6.1 United States Procalcitonin Antibody Sales Market Share by Company (2015-2020)
6.2 United States Procalcitonin Antibody Sales Market Share by Type (2015-2020)
6.3 United States Procalcitonin Antibody Sales Market Share by Application (2015-2020)
7 Europe Procalcitonin Antibody Market Facts & Figures
7.1 Europe Procalcitonin Antibody Sales Market Share by Company (2015-2020)
7.2 Europe Procalcitonin Antibody Sales Market Share by Type (2015-2020)
7.3 Europe Procalcitonin Antibody Sales Market Share by Application (2015-2020)
8 China Procalcitonin Antibody Market Facts & Figures
8.1 China Procalcitonin Antibody Sales Market Share by Company (2015-2020)
8.2 China Procalcitonin Antibody Sales Market Share by Type (2015-2020)
8.3 China Procalcitonin Antibody Sales Market Share by Application (2015-2020)
9 Japan Procalcitonin Antibody Market Facts & Figures
9.1 Japan Procalcitonin Antibody Sales Market Share by Company (3015-3030)
9.2 Japan Procalcitonin Antibody Sales Market Share by Type (2015-2020)
9.3 Japan Procalcitonin Antibody Sales Market Share by Application (2015-2020)
10 Southeast Asia Procalcitonin Antibody Market Facts & Figures
10.1 Southeast Asia Procalcitonin Antibody Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Procalcitonin Antibody Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Procalcitonin Antibody Sales Market Share by Application (2015-2020)
11 India Procalcitonin Antibody Market Facts & Figures
11.1 India Procalcitonin Antibody Sales Market Share by Company (2015-2020)
11.2 India Procalcitonin Antibody Sales Market Share by Type (2015-2020)
11.3 India Procalcitonin Antibody Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Procalcitonin Antibody Business
12.1 Thermo Fisher
12.1.1 Thermo Fisher Corporation Information
12.1.2 Thermo Fisher Business Overview
12.1.3 Thermo Fisher Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Thermo Fisher Procalcitonin Antibody Products Offered
12.1.5 Thermo Fisher Recent Development
12.2 Roche Diagnostics
12.2.1 Roche Diagnostics Corporation Information
12.2.2 Roche Diagnostics Business Overview
12.2.3 Roche Diagnostics Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Roche Diagnostics Procalcitonin Antibody Products Offered
12.2.5 Roche Diagnostics Recent Development
12.3 bioMerieux
12.3.1 bioMerieux Corporation Information
12.3.2 bioMerieux Business Overview
12.3.3 bioMerieux Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.3.4 bioMerieux Procalcitonin Antibody Products Offered
12.3.5 bioMerieux Recent Development
12.4 HyTest
12.4.1 HyTest Corporation Information
12.4.2 HyTest Business Overview
12.4.3 HyTest Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.4.4 HyTest Procalcitonin Antibody Products Offered
12.4.5 HyTest Recent Development
12.5 Wondfo
12.5.1 Wondfo Corporation Information
12.5.2 Wondfo Business Overview
12.5.3 Wondfo Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Wondfo Procalcitonin Antibody Products Offered
12.5.5 Wondfo Recent Development
12.6 Ningbo Medicalsystem Biotechnology
12.6.1 Ningbo Medicalsystem Biotechnology Corporation Information
12.6.2 Ningbo Medicalsystem Biotechnology Business Overview
12.6.3 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Products Offered
12.6.5 Ningbo Medicalsystem Biotechnology Recent Development
12.7 Snibe
12.7.1 Snibe Corporation Information
12.7.2 Snibe Business Overview
12.7.3 Snibe Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Snibe Procalcitonin Antibody Products Offered
12.7.5 Snibe Recent Development
12.8 Vazyme Biotech
12.8.1 Vazyme Biotech Corporation Information
12.8.2 Vazyme Biotech Business Overview
12.8.3 Vazyme Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Vazyme Biotech Procalcitonin Antibody Products Offered
12.8.5 Vazyme Biotech Recent Development
12.9 Getein Biotech
12.9.1 Getein Biotech Corporation Information
12.9.2 Getein Biotech Business Overview
12.9.3 Getein Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Getein Biotech Procalcitonin Antibody Products Offered
12.9.5 Getein Biotech Recent Development
12.10 Hotgen Biotech
12.10.1 Hotgen Biotech Corporation Information
12.10.2 Hotgen Biotech Business Overview
12.10.3 Hotgen Biotech Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Hotgen Biotech Procalcitonin Antibody Products Offered
12.10.5 Hotgen Biotech Recent Development
12.11 Lumigenex
12.11.1 Lumigenex Corporation Information
12.11.2 Lumigenex Business Overview
12.11.3 Lumigenex Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Lumigenex Procalcitonin Antibody Products Offered
12.11.5 Lumigenex Recent Development
12.12 Shanghai Medicine’nest Pharmaceutical
12.12.1 Shanghai Medicine’nest Pharmaceutical Corporation Information
12.12.2 Shanghai Medicine’nest Pharmaceutical Business Overview
12.12.3 Shanghai Medicine’nest Pharmaceutical Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Shanghai Medicine’nest Pharmaceutical Procalcitonin Antibody Products Offered
12.12.5 Shanghai Medicine’nest Pharmaceutical Recent Development
12.13 Kitgen
12.13.1 Kitgen Corporation Information
12.13.2 Kitgen Business Overview
12.13.3 Kitgen Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Kitgen Procalcitonin Antibody Products Offered
12.13.5 Kitgen Recent Development
12.14 Beijing KeyGen
12.14.1 Beijing KeyGen Corporation Information
12.14.2 Beijing KeyGen Business Overview
12.14.3 Beijing KeyGen Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Beijing KeyGen Procalcitonin Antibody Products Offered
12.14.5 Beijing KeyGen Recent Development
12.15 Fantibody
12.15.1 Fantibody Corporation Information
12.15.2 Fantibody Business Overview
12.15.3 Fantibody Procalcitonin Antibody Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Fantibody Procalcitonin Antibody Products Offered
12.15.5 Fantibody Recent Development
13 Procalcitonin Antibody Manufacturing Cost Analysis
13.1 Procalcitonin Antibody Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Procalcitonin Antibody
13.4 Procalcitonin Antibody Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Procalcitonin Antibody Distributors List
14.3 Procalcitonin Antibody Customers
15 Market Dynamics
15.1 Procalcitonin Antibody Market Trends
15.2 Procalcitonin Antibody Opportunities and Drivers
15.3 Procalcitonin Antibody Market Challenges
15.4 Procalcitonin Antibody Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Procalcitonin Antibody Sales (mg) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Procalcitonin Antibody Sales (mg) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Procalcitonin Antibody Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Procalcitonin Antibody Sales (mg) by Region (2015-2020)
Table 5. Global Procalcitonin Antibody Sales Market Share by Region (2015-2020)
Table 6. Global Procalcitonin Antibody Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Procalcitonin Antibody Revenue Share by Region (2015-2020)
Table 8. Global Procalcitonin Antibody Sales (mg) Forecast by Region (2021-2026)
Table 9. Global Procalcitonin Antibody Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Procalcitonin Antibody Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Procalcitonin Antibody Revenue Share Forecast by Region (2021-2026)
Table 12. Global Procalcitonin Antibody (mg) of Key Companies (2015-2020)
Table 13. Global Procalcitonin Antibody Sales Share by Company (2015-2020)
Table 14. Global Procalcitonin Antibody Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Procalcitonin Antibody Revenue Share by Company (2015-2020)
Table 16. Global Procalcitonin Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Procalcitonin Antibody as of 2019)
Table 17. Global Procalcitonin Antibody Average Price (USD/mg) of Key Company (2015-2020)
Table 18. Manufacturers Procalcitonin Antibody Manufacturing Sites and Area Served
Table 19. Manufacturers Procalcitonin Antibody Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Procalcitonin Antibody Players
Table 22. Global Procalcitonin Antibody Sales (mg) by Type (2015-2020)
Table 23. Global Procalcitonin Antibody Sales Share by Type (2015-2020)
Table 24. Global Procalcitonin Antibody Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Procalcitonin Antibody Price (mg) by Type (2015-2020)
Table 26. Global Procalcitonin Antibody Sales Share by Type (2021-2026)
Table 27. Global Procalcitonin Antibody Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Procalcitonin Antibody Revenue Share by Type (2021-2026)
Table 29. Global Procalcitonin Antibody Price (mg) by Type (2021-2026)
Table 30. Global Procalcitonin Antibody Sales (mg) by Application (2015-2020)
Table 31. Global Procalcitonin Antibody Sales Share by Application (2015-2020)
Table 32. Global Procalcitonin Antibody Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Procalcitonin Antibody Price (mg) by Application (2015-2020)
Table 34. Global Procalcitonin Antibody Sales (mg) by Application (2021-2026)
Table 35. Global Procalcitonin Antibody Sales Share by Application (2021-2026)
Table 36. Global Procalcitonin Antibody Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Procalcitonin Antibody Revenue Share by Application (2021-2026)
Table 38. Global Procalcitonin Antibody Price (mg) by Application (2021-2026)
Table 39. United States Procalcitonin Antibody Sales (mg) by Company (2015-2020)
Table 40. United States Procalcitonin Antibody Sales Market Share by Company (2015-2020)
Table 41. United States Procalcitonin Antibody Sales (mg) by Type (2015-2020)
Table 42. United States Procalcitonin Antibody Sales Market Share by Type (2015-2020)
Table 43. United States Procalcitonin Antibody Sales (mg) by Application (2015-2020)
Table 44. United States Procalcitonin Antibody Sales Market Share by Application (2015-2020)
Table 45. Europe Procalcitonin Antibody Sales (mg) by Company (2015-2020)
Table 46. Europe Procalcitonin Antibody Sales Market Share by Company (2015-2020)
Table 47. Europe Procalcitonin Antibody Sales (mg) by Type (2015-2020)
Table 48. Europe Procalcitonin Antibody Sales Market Share by Type (2015-2020)
Table 49. Europe Procalcitonin Antibody Sales (mg) by Application (2015-2020)
Table 50. Europe Procalcitonin Antibody Sales Market Share by Type (2015-2020)
Table 51. China Procalcitonin Antibody Sales (mg) by Company (2015-2020)
Table 52. China Procalcitonin Antibody Sales Market Share by Company (2015-2020)
Table 53. China Procalcitonin Antibody Sales (mg) by Type (2015-2020)
Table 54. China Procalcitonin Antibody Sales Market Share by Type (2015-2020)
Table 55. China Procalcitonin Antibody Sales (mg) by Application (2015-2020)
Table 56. China Procalcitonin Antibody Sales Market Share by Application (2015-2020)
Table 57. Japan Procalcitonin Antibody Sales (mg) by Company (2015-2020)
Table 58. Japan Procalcitonin Antibody Sales Market Share by Company (2015-2020)
Table 59. Japan Procalcitonin Antibody Sales (mg) by Type (2015-2020)
Table 60. Japan Procalcitonin Antibody Sales Market Share by Type (2015-2020)
Table 61. Japan Procalcitonin Antibody Sales (mg) by Application (2015-2020)
Table 62. Japan Procalcitonin Antibody Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Procalcitonin Antibody Sales (mg) by Company (2015-2020)
Table 64. Southeast Asia Procalcitonin Antibody Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Procalcitonin Antibody Sales (mg) by Type (2015-2020)
Table 66. Southeast Asia Procalcitonin Antibody Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Procalcitonin Antibody Sales (mg) by Type (2015-2020)
Table 68. Southeast Asia Procalcitonin Antibody Sales Market Share by Application (2015-2020)
Table 69. India Procalcitonin Antibody Sales (mg) by Company (2015-2020)
Table 70. India Procalcitonin Antibody Sales Market Share by Company (2015-2020)
Table 71. India Procalcitonin Antibody Sales (mg) by Type (2015-2020)
Table 72. India Procalcitonin Antibody Sales Market Share by Type (2015-2020)
Table 73. India Procalcitonin Antibody Sales (mg) by Application (2015-2020)
Table 74. India Procalcitonin Antibody Sales Market Share by Application (2015-2020)
Table 75. Thermo Fisher Corporation Information
Table 76. Thermo Fisher Description and Business Overview
Table 77. Thermo Fisher Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 78. Thermo Fisher Procalcitonin Antibody Product
Table 79. Thermo Fisher Recent Development
Table 80. Roche Diagnostics Corporation Information
Table 81. Roche Diagnostics Description and Business Overview
Table 82. Roche Diagnostics Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 83. Roche Diagnostics Procalcitonin Antibody Product
Table 84. Roche Diagnostics Recent Development
Table 85. bioMerieux Corporation Information
Table 86. bioMerieux Description and Business Overview
Table 87. bioMerieux Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 88. bioMerieux Procalcitonin Antibody Product
Table 89. bioMerieux Recent Development
Table 90. HyTest Corporation Information
Table 91. HyTest Description and Business Overview
Table 92. HyTest Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 93. HyTest Procalcitonin Antibody Product
Table 94. HyTest Recent Development
Table 95. Wondfo Corporation Information
Table 96. Wondfo Description and Business Overview
Table 97. Wondfo Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 98. Wondfo Procalcitonin Antibody Product
Table 99. Wondfo Recent Development
Table 100. Ningbo Medicalsystem Biotechnology Corporation Information
Table 101. Ningbo Medicalsystem Biotechnology Description and Business Overview
Table 102. Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 103. Ningbo Medicalsystem Biotechnology Procalcitonin Antibody Product
Table 104. Ningbo Medicalsystem Biotechnology Recent Development
Table 105. Snibe Corporation Information
Table 106. Snibe Description and Business Overview
Table 107. Snibe Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 108. Snibe Procalcitonin Antibody Product
Table 109. Snibe Recent Development
Table 110. Vazyme Biotech Corporation Information
Table 111. Vazyme Biotech Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 112. Vazyme Biotech Description and Business Overview
Table 113. Vazyme Biotech Procalcitonin Antibody Product
Table 114. Vazyme Biotech Recent Development
Table 115. Getein Biotech Corporation Information
Table 116. Getein Biotech Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 117. Getein Biotech Description and Business Overview
Table 118. Getein Biotech Procalcitonin Antibody Product
Table 119. Getein Biotech Recent Development
Table 120. Hotgen Biotech Corporation Information
Table 121. Hotgen Biotech Description and Business Overview
Table 122. Hotgen Biotech Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 123. Hotgen Biotech Procalcitonin Antibody Product
Table 124. Hotgen Biotech Recent Development
Table 125. Lumigenex Corporation Information
Table 126. Lumigenex Description and Business Overview
Table 127. Lumigenex Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 128. Lumigenex Procalcitonin Antibody Product
Table 129. Lumigenex Recent Development
Table 130. Shanghai Medicine'nest Pharmaceutical Corporation Information
Table 131. Shanghai Medicine'nest Pharmaceutical Description and Business Overview
Table 132. Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 133. Shanghai Medicine'nest Pharmaceutical Procalcitonin Antibody Product
Table 134. Shanghai Medicine'nest Pharmaceutical Recent Development
Table 135. Kitgen Corporation Information
Table 136. Kitgen Description and Business Overview
Table 137. Kitgen Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 138. Kitgen Procalcitonin Antibody Product
Table 139. Kitgen Recent Development
Table 140. Beijing KeyGen Corporation Information
Table 141. Beijing KeyGen Description and Business Overview
Table 142. Beijing KeyGen Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 143. Beijing KeyGen Procalcitonin Antibody Product
Table 144. Beijing KeyGen Recent Development
Table 145. Fantibody Corporation Information
Table 146. Fantibody Description and Business Overview
Table 147. Fantibody Procalcitonin Antibody Sales (mg), Revenue (Million USD), Price (USD/mg) and Gross Margin (2015-2020)
Table 148. Fantibody Procalcitonin Antibody Product
Table 149. Fantibody Recent Development
Table 150. Production Base and Market Concentration Rate of Raw Material
Table 151. Key Suppliers of Raw Materials
Table 152. Procalcitonin Antibody Distributors List
Table 153. Procalcitonin Antibody Customers List
Table 154. Procalcitonin Antibody Market Key Trends
Table 155. Procalcitonin Antibody Key Opportunities and Drivers
Table 156. Procalcitonin Antibody Market Challenges
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Procalcitonin Antibody Product Picture
Figure 2. Global Procalcitonin Antibody Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Procalcitonin Antibody Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Medical research institutions Examples
Figure 8. Others Examples
Figure 9. Global Procalcitonin Antibody Sales (mg) Growth Rate (2015-2026)
Figure 10. Global Procalcitonin Antibody Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Procalcitonin Antibody Price Trends Growth Rate (2015-2026) (USD/mg)
Figure 12. Global Procalcitonin Antibody Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Procalcitonin Antibody Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Procalcitonin Antibody Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Procalcitonin Antibody Sales (mg) Growth Rate (2015-2026)
Figure 16. Europe Procalcitonin Antibody Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Procalcitonin Antibody Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Procalcitonin Antibody Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Procalcitonin Antibody Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Procalcitonin Antibody Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Procalcitonin Antibody Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Procalcitonin Antibody Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Procalcitonin Antibody Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Procalcitonin Antibody Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Procalcitonin Antibody Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Procalcitonin Antibody Players Market Share by Revenue in Procalcitonin Antibody 2015 & 2019
Figure 27. Procalcitonin Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Procalcitonin Antibody Revenue Share by Type (2015-2020)
Figure 29. Global Procalcitonin Antibody Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Procalcitonin Antibody Revenue Share by Application (2015-2020)
Figure 31. Global Procalcitonin Antibody Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Procalcitonin Antibody Sales Market Share by Type in 2019
Figure 33. United States Procalcitonin Antibody Sales Market Share by Type in 2019
Figure 34. Europe Procalcitonin Antibody Sales Market Share by Company in 2019
Figure 35. Europe Procalcitonin Antibody Sales Market Share by Type in 2019
Figure 36. Europe Procalcitonin Antibody Sales Market Share by Application in 2019
Figure 37. China Procalcitonin Antibody Sales Market Share by Company in 2019
Figure 38. China Procalcitonin Antibody Sales Market Share by Type in 2019
Figure 39. China Procalcitonin Antibody Sales Market Share by Application in 2019
Figure 40. Japan Procalcitonin Antibody Sales Market Share by Company in 2019
Figure 41. Japan Procalcitonin Antibody Sales Market Share by Type in 2019
Figure 42. Japan Procalcitonin Antibody Sales Market Share by Application in 2019
Figure 43. Southeast Asia Procalcitonin Antibody Sales Market Share by Company in 2019
Figure 44. Southeast Asia Procalcitonin Antibody Sales Market Share by Type in 2019
Figure 45. Southeast Asia Procalcitonin Antibody Sales Market Share by Application in 2019
Figure 46. India Procalcitonin Antibody Sales Market Share by Company in 2019
Figure 47. India Procalcitonin Antibody Sales Market Share by Type in 2019
Figure 48. India Procalcitonin Antibody Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Procalcitonin Antibody
Figure 51. Manufacturing Process Analysis of Procalcitonin Antibody
Figure 52. Procalcitonin Antibody Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
プロカルシトニンの世界市場レポート2020 Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved i…- フラグメント抗体の世界市場レポート2020 Market Analysis and Insights: Global Antibody Fragments Market The global Antibody Fragments market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Antibody Fragments Scope and Market Size The global Antibody Fragments market …
- プロカルシトニン迅速検査キットの世界市場レポート2020 Market Analysis and Insights: Global Procalcitonin Rapid Test Kit Market The global Procalcitonin Rapid Test Kit market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Procalcitonin Rapid Test Kit Scope and Market Size The glo…
- 幹細胞抗体の世界市場レポート2020 Market Analysis and Insights: Global Stem Cell Antibody Market The global Stem Cell Antibody market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Stem Cell Antibody Scope and Market Size The global Stem Cell Antibody market …
- シングルユースバイオプロセシングの世界市場レポート2020 Market Analysis and Insights: Global Single-use Bioprocessing Market The global Single-use Bioprocessing market size is projected to reach US$ 6318.2 million by 2026, from US$ 3548.5 million in 2020, at a CAGR of 10.1% during 2021-2026. Global Single-use Bioprocessing Scope and Market Size The globa…